NCT04955899View on ClinicalTrials.gov

Safety of Splenic Stimulation for RA

NARecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions
Rheumatoid Arthritis
Interventions
DEVICE

Active Stimulation

The Galvani System will be implanted in eligible participants, and stimulation will be turned ON

Trial Locations (2)

Unknown

RECRUITING

Academic Medical Center (AMC) Dept of Rheumatology & Clinical Immunology, Amsterdam

G12 OXH

RECRUITING

Greater Glasgow Health Board, Glasgow

Sponsors

Collaborators (1)

NAMSA
All Listed Sponsors
collaborator

NAMSA

OTHER

lead

Galvani Bioelectronics

INDUSTRY

NCT04955899 - Safety of Splenic Stimulation for RA | Biotech Hunter | Biotech Hunter